Related Experiment Video
Updated: Jun 4, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
New therapeutic options in the medical management of advanced melanoma
1Melanoma Program, Division of Hematology/Oncology, Mount Sinai Comprehensive Cancer Center, Miami Beach, FL, USA. jlutzky@aptiumoncology.com
Abstract:
During the past 3 decades, the incidence, morbidity, and mortality of malignant melanoma have increased dramatically. Advanced melanoma has remained a disease that is for the most part incurable and has challenged all therapeutic efforts to make a dent in its natural history. Recent advances in the understanding of the molecular alterations in melanoma and in the immunologic mechanisms playing a role in this malignancy have brought hope that significant progress can be achieved, as evidenced by early encouraging clinical data. This review will summarize these recent developments and their impact on current clinical practice.
Insights
Malignant melanoma incidence is rising, with advanced stages proving difficult to treat. Recent breakthroughs in understanding melanoma's molecular and immunological aspects offer new therapeutic hope.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Malignant melanoma incidence, morbidity, and mortality have significantly increased over the last 30 years.
- Advanced melanoma remains largely incurable, posing a substantial challenge to therapeutic interventions.
- Limited progress has been made in altering the natural history of advanced melanoma.
Purpose of the Study:
- To review recent advancements in understanding melanoma.
- To discuss the impact of new findings on clinical practice.
- To highlight progress in treating malignant melanoma.
Main Methods:
- Literature review of recent studies on melanoma.
- Analysis of molecular alterations in melanoma.
- Examination of immunologic mechanisms in melanoma.
Main Results:
- Recent advances in molecular and immunological understanding offer hope for melanoma treatment.
- Early clinical data suggest significant progress is achievable.
- New insights are impacting current clinical practices for melanoma management.
Conclusions:
- Understanding melanoma's molecular and immunological basis is crucial for therapeutic development.
- Emerging treatments show promise for improving outcomes in advanced melanoma.
- Continued research is vital to combat the rising burden of malignant melanoma.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

